SCHEMBL688471

SCHEMBL688471

C#Cc1ccccc1C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.56
ALOX15 P16050 2/20 0.56
CA12 O43570 3/20 0.48
CA1 P00915 3/20 0.48
CA2 P00918 3/20 0.48
CA4 P22748 3/20 0.48
CA7 P43166 3/20 0.48
CA9 Q16790 3/20 0.48
KDM4E B2RXH2 1/20 0.48
HMGB1 P09429 1/20 0.48
HPGD P15428 1/20 0.48
CA6 P23280 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
NAPRT Q6XQN6 1/20 0.48
CA14 Q9ULX7 1/20 0.48
MAPT P10636 2/20 0.46
HDAC8 Q9BY41 1/20 0.46
POLB P06746 1/20 0.45
AKR1C3 P42330 1/20 0.45
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL29290216 1.00 ALDH1A1 (0.56) ALDH1A1ALOX15CA12CA1CA2
Hydrochloric Acid SCHEMBL10490986 0.98 ALDH1A1 (0.54) ALDH1A1ALOX15CA12CA1CA2
SCHEMBL402519 0.94 ALDH1A1 (0.50) ALDH1A1ALOX15CA12CA1CA2
Naphthalene SCHEMBL28214618 0.94 ALDH1A1 (0.50) ALDH1A1ALOX15CA12CA1CA2
Hydrochloric Acid SCHEMBL2707920 0.92 ALDH1A1 (0.48) ALDH1A1ALOX15CA12CA1CA2
Anthracene SCHEMBL28077524 0.90 IDO1 (0.47) ALDH1A1ALOX15CA12CA1CA2
SCHEMBL1927621 0.89 ACMSD (0.50) ALDH1A1ALOX15HPGDTSHRNR4A1
Anisole SCHEMBL28354532 0.86 USP2 (0.49) ALDH1A1ALOX15CA1CA2CA4
SCHEMBL7557424 0.84 NPC1 (0.41) ALDH1A1ALOX15CA12CA1CA2
SCHEMBL5666504 0.83 ALDH1A1 (0.46) ALDH1A1ALOX15CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120025276-A Phenolic butane hapten compound, preparation method thereof, complete antigen and application 公安部第三研究所 2025-05-23 CN claimed
CN-120025275-A Halogen substituted phenol butane hapten compound and preparation method and application thereof 公安部第三研究所 2025-05-23 CN claimed
CN-119318887-A Graphite alkyne multilayer composite membrane and preparation method thereof 北京化工大学 2025-01-17 CN claimed
CN-115869785-B Ultrafast preparation method of graphite alkyne composite membrane 北京化工大学 2024-11-26 CN claimed
CN-115869785-A Ultrafast preparation method of graphite alkyne composite membrane 北京化工大学 2023-03-31 CN claimed
CN-113402644-B Water-soluble active ester polymer and synthesis method and application thereof 苏州嘉佑生物科技有限公司 2022-09-06 CN claimed
CN-110590734-B Method for synthesizing 2-methyl-4H-benzo [ d ] [1,3] oxathiacyclohexadiene-4-one 常州大学 2022-03-25 CN claimed
CN-110590734-A Method for synthesizing 2-methyl-4H-benzo [ d ] [1,3] oxathiacyclohexadiene-4-one 常州大学 2019-12-20 CN claimed
CN-109134533-A A kind of phosphorus-containing compound and its preparation and application 维眸生物科技(上海)有限公司 2019-01-04 CN claimed
US-9868820-B2 Polyarylene materials ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2018-01-16 US claimed
CN-106588525-A Method for synthesizing ph-dicarbonyl-aryl-formic-ether series compounds based on metal-free participation method 嘉兴学院 2017-04-26 CN claimed
US-20160060393-A1 POLYARYLENE MATERIALS U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2016-03-03 US claimed
EP-2990430-A1 POLYARYLENE MATERIALS Rohm and Haas Electronic Materials LLC (US) 2016-03-02 EP claimed
US-8492507-B2 Acetylenic polyamide NEXAM CHEMICAL AB (SE) 2013-07-23 US claimed
US-20110190469-A1 ACETYLENIC POLYAMIDE NEXAM CHEMICAL AB (SE) 2011-08-04 US claimed
EP-2344568-A1 ACETYLENIC POLYAMIDE Nexam Chemical AB (SE) 2011-07-20 EP claimed
WO-2010036170-A1 ACETYLENIC POLYAMIDE NEXAM CHEMICAL AB (SE) 2010-04-01 WO claimed
WO-2010030216-A1 ACETYLENIC POLY(ALKYLENE PHTHALATE) NEXAM CHEMICAL AB (SE) 2010-03-18 WO claimed
US-20080161325-A1 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome ELAN PHARMACEUTICALS, INC. 2008-07-03 US claimed
EP-0050428-A1 Ethynylated aromatic compounds and process for making same Hughes Aircraft Company (US) 1982-04-28 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161325-A1 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome BACE1, APP, BACE2 ALDH1A1 2178/4885ALOX15 1385/4885CA12 4081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.